Embargoed for Wednesday, September 9, 2015

PETER JONES FOR JDRF IN SCOTLAND SETS OUT PERSONAL VISION TO SEE SCOTLAND PLAY KEY ROLE IN CURE FOR TYPE 1 DIABETES

The type 1 diabetes charity JDRF has appointed Peter Jones, managing director of international energy company Taqa in Europe, as chairman of its development group in Scotland.

Peter (43), who lives with the condition himself, joins JDRF to spearhead a £750,000 fundraising campaign to support research carried out in Scotland and brings with him a vision to see Scotland play a far greater role in the development of a cure.

Scotland has one of the highest incidences of type 1diabetes in the world. Over 28,500 people in Scotland live with the condition and incidence is increasing by around four per cent each year, particularly in children under five. Dedicated to research into type 1, JDRF is already funding £3.9m worth of projects in Scotland, and Peter wants to see more of Scotland’s research community taking up the challenge of accelerating the pace of research and helping JDRF find the cure.

On taking up the voluntary position in the JDRF Scottish headquarters in Aberdeen, he said:

“I was drawn to JDRF as a charity because of its laser focus on type 1 diabetes, improving the lives of people living with it, and finding the cure.  With every new project they are another step closer. For those like me living with the condition, or those with type 1 in their families, it is a tremendously uplifting prospect and I am delighted to now be closely involved in that evolving success story.

“In taking on this role I want to inspire others with the prospect of finding a cure. With the third highest incidence of type 1 diabetes in Europe, Scotland has a worryingly high level of people with the condition, but we also have one of the leading life sciences and media research communities in the world. I believe Scotland is perfectly placed to drive new research and play a major role in the development of a cure.”

Type 1 diabetes is an autoimmune condition. Those with type 1 cannot produce the insulin that regulates their blood glucose levels because their immune system, for reasons not yet fully understood, attacks and destroys the insulin producing cells in the pancreas. There is no known cure, but researchers believe that finding a cure for type 1 will also offer new treatments for those with type 2 diabetes.

JDRF is the world’s leading charitable funder of type 1 diabetes research and is currently sponsoring work at the University of Glasgow and the University of Dundee that focuses on the treatment of type 1 diabetes and its associated complications.

Peter added:

“We are determined to raise the funds to continue to support important research projects in Scotland, but I want to go further. We are about to set out on a campaign to raise awareness of the importance of JDRF research and how and why Scotland’s medical and academic community, the politicians and families affected should support a cause that could make Scotland a world leader in type 1 research.”

Notes to Editors

About JDRF

JDRF exists to find the cure for type 1 diabetes and its complications, and is the world’s leading type 1 diabetes research charity.  At a global level, JDRF volunteers and staff have been responsible for raising over £1 billion to support type 1 diabetes research, since the charity’s inception.www.jdrf.org.uk

About type 1 diabetes:

  •        Type 1 diabetes is a chronic condition that has a life-long impact on those diagnosed with it and their families. JDRF exists to find the cure for type 1 diabetes.
  •        Type 1 diabetes is an autoimmune condition that cannot be prevented, and is not linked to lifestyle factors such as diet and exercise.
  •        People with type 1 diabetes rely on multiple insulin injections or pump infusions every day just to stay alive, until we find the cure.
  •        It normally strikes children and stays with them for the rest of their lives.
  •        Type 1 diabetes affects about 400,000 people in the UK, 29,000 of them children.

Peter Jones:

Peter Jones was appointed managing director for Taqa UK in July 2013, before being made MD for Taqa Europe in July 2015. Having first graduated from the University of Stirling with a degree in economics, he went on to study for a second degree in engineering at the University of Birmingham. After a brief spell in academia, Peter’s career has been in the oil and gas industry, based in both the UK and in the United States of America.

For further information, please contact:

Elizabeth Lambley, Indigo, 0131 554 1230, lizzylambley@indigopr.com

Claire Douglas, Regional Fundraiser (Scotland), JDRF cdouglas@jdrf.org.uk

Tags:

About Us

Taking care of your reputation, so you can take care of business Indigo is proud to be an independent Scottish company that has retained its key values of being ethical, practical and professional. When we were established in 1998, we knew we were different. From the outset, we saw it as our role to raise and sustain our clients' public profile in a credible, structured and controlled manner, using a range of communications tools. If we do sound like the kind of peopleyou’d like to do business with,call 0131 554 1230. The Indigo team offers effective and innovative reputation management for companies and individuals using the tools of media relations, PR, public affairs and crisis management. We are proud that we can let our reputation and work speak for itself, as seen in our collection of hard-earned industry awards when you visit the office in Edinburgh. But what matters more to us are our clients.

Media

Media

Quick facts

Over 28,500 people in Scotland live with type 1 diabetes
Tweet this
JDRF has committed £3.9m to fund research in Scotland
Tweet this
Type 1 diabetes is a chronic condition that has a life-long impact on those diagnosed with it and their families
Tweet this

Quotes

I was drawn to JDRF as a charity because of its laser focus on type 1 diabetes, and finding the cure
Pete Jones